Market Overview:
The global aortic endografts market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of aortic aneurysms and rising demand for minimally invasive surgeries. Based on type, the global aortic endografts market is segmented into abdominal aortic endografts, thoracic aortic endografts, fenestrated and branched aortic endografts, and flow diverting aortic endografts. The abdominal segment is expected to account for the largest share of the global market in 2018 owing to the high prevalence of abdominal aneurysms. By application, hospitals are expected to account for the largest share of the global market in 2018 followed by clinics.
Product Definition:
Aortic endografts are devices used to repair aortic aneurysms. They are tubes made of metal or fabric that are inserted into the aorta through a large artery in the leg. The endograft is then inflated with air or saline to seal off the aneurysm.
Abdominal Aortic Endografts:
Abdominal Aortic Endografts (AAE) is a surgical procedure used to replace the damaged or diseased part of the aorta. It's an artificial device made up of tissue that is intended to support the flow of blood in case of severe abdominal aortic aneurysm.
Thoracic Aortic Endografts:
The thoracic aortic endografts are used in the reconstruction of the thoracic aorta and it's branches. The most commonly accepted method for replacing damaged or diseased Thoracic Aorta is by using an endograft. An endograft is a surgical graft that consists of tissue, which is taken from either the patient’s body or from donor tissues (specimens).
Application Insights:
Based on application, the global aortic endografts market is segmented into hospitals, clinics and other medical facilities, and others. Hospitals held the largest share in 2017 owing to factors such as increasing prevalence of cardiovascular diseases along with an aging population that requires a large number of surgeries. According to data published by WHO in 2018, around 1 in 3 deaths occur due to CVD globally. Thus, increasing incidence coupled with rising healthcare costs is driving the adoption of minimally invasive procedures such as aortic endografts at hospitals across the globe.
The clinics and other medical facilities segment is expected register significant growth over the forecast period owing to growing awareness about various benefits associated with these devices including shorter hospital stay duration post-surgery along with reduced risk of blood clots forming within the body after surgery which can lead to life-threatening conditions such as stroke or heart attack later on.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing incidence of aortic dissection and other associated conditions, such as Marfan syndrome and Turner syndrome among others. In addition, rising geriatric population is also contributing towards the high prevalence of these diseases in this region. According to data published by National Center for Health Statistics (NCHS), around 3% to 4% of adults aged 65 years or more have been identified with Marfan syndrome while 1% to 2% have been diagnosed with Turner Syndrome.
Growth Factors:
- Increasing incidence of aortic aneurysms and aortic dissections
- Growing demand for minimally invasive surgeries
- Rising geriatric population susceptible to aortic diseases
- Technological advancements in endografts design and manufacturing
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Aortic Endografts Market Research Report
By Type
Abdominal Aortic Endografts, Thoracic Aortic Endografts, Fenestrated and Branched Aortic Endografts, Flow Diverting Aortic Endografts,
By Application
Hospitals, Clinics, Others,
By Companies
Bolton Medical, Braile Biomedica, Cardiatis, Cook Medical, Cordis (Cardinal Health), Endologix, Inc., Endospan, Jotec, Lombard Medical Technologies Plc, Medtronic Plc, Microport Medical, Nano Endoluminal, Terumo Medical Corp., Transcatheter Technologies, TriVascular Inc., Vascutek, W. L. Gore and Associates
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Aortic Endografts Market Report Segments:
The global Aortic Endografts market is segmented on the basis of:
Types
Abdominal Aortic Endografts, Thoracic Aortic Endografts, Fenestrated and Branched Aortic Endografts, Flow Diverting Aortic Endografts,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bolton Medical
- Braile Biomedica
- Cardiatis
- Cook Medical
- Cordis (Cardinal Health)
- Endologix, Inc.
- Endospan
- Jotec
- Lombard Medical Technologies Plc
- Medtronic Plc
- Microport Medical
- Nano Endoluminal
- Terumo Medical Corp.
- Transcatheter Technologies
- TriVascular Inc.
- Vascutek
- W. L. Gore and Associates
Highlights of The Aortic Endografts Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Abdominal Aortic Endografts
- Thoracic Aortic Endografts
- Fenestrated and Branched Aortic Endografts
- Flow Diverting Aortic Endografts
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aortic Endografts Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aortic endografts are a type of artificial heart valve. They are made from a patient's own tissue and are inserted into the person's aorta (the large artery that carries blood from the heart to other parts of the body). The graft helps replace an old or damaged valve, which can reduce the risk of heart attack or stroke.
Some of the major players in the aortic endografts market are Bolton Medical, Braile Biomedica, Cardiatis, Cook Medical, Cordis (Cardinal Health), Endologix, Inc., Endospan, Jotec, Lombard Medical Technologies Plc, Medtronic Plc, Microport Medical, Nano Endoluminal, Terumo Medical Corp., Transcatheter Technologies, TriVascular Inc., Vascutek, W. L. Gore and Associates.
The aortic endografts market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Aortic Endografts Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Aortic Endografts Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Aortic Endografts Market - Supply Chain
4.5. Global Aortic Endografts Market Forecast
4.5.1. Aortic Endografts Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Aortic Endografts Market Size (000 Units) and Y-o-Y Growth
4.5.3. Aortic Endografts Market Absolute $ Opportunity
5. Global Aortic Endografts Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Aortic Endografts Market Size and Volume Forecast by Type
5.3.1. Abdominal Aortic Endografts
5.3.2. Thoracic Aortic Endografts
5.3.3. Fenestrated and Branched Aortic Endografts
5.3.4. Flow Diverting Aortic Endografts
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Aortic Endografts Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Aortic Endografts Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Aortic Endografts Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Aortic Endografts Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Aortic Endografts Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Aortic Endografts Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Aortic Endografts Demand Share Forecast, 2019-2026
9. North America Aortic Endografts Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Aortic Endografts Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Aortic Endografts Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Aortic Endografts Market Size and Volume Forecast by Type
9.7.1. Abdominal Aortic Endografts
9.7.2. Thoracic Aortic Endografts
9.7.3. Fenestrated and Branched Aortic Endografts
9.7.4. Flow Diverting Aortic Endografts
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Aortic Endografts Demand Share Forecast, 2019-2026
10. Latin America Aortic Endografts Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Aortic Endografts Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Aortic Endografts Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Aortic Endografts Market Size and Volume Forecast by Type
10.7.1. Abdominal Aortic Endografts
10.7.2. Thoracic Aortic Endografts
10.7.3. Fenestrated and Branched Aortic Endografts
10.7.4. Flow Diverting Aortic Endografts
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Aortic Endografts Demand Share Forecast, 2019-2026
11. Europe Aortic Endografts Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Aortic Endografts Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Aortic Endografts Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Aortic Endografts Market Size and Volume Forecast by Type
11.7.1. Abdominal Aortic Endografts
11.7.2. Thoracic Aortic Endografts
11.7.3. Fenestrated and Branched Aortic Endografts
11.7.4. Flow Diverting Aortic Endografts
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Aortic Endografts Demand Share, 2019-2026
12. Asia Pacific Aortic Endografts Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Aortic Endografts Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Aortic Endografts Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Aortic Endografts Market Size and Volume Forecast by Type
12.7.1. Abdominal Aortic Endografts
12.7.2. Thoracic Aortic Endografts
12.7.3. Fenestrated and Branched Aortic Endografts
12.7.4. Flow Diverting Aortic Endografts
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Aortic Endografts Demand Share, 2019-2026
13. Middle East & Africa Aortic Endografts Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Aortic Endografts Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Aortic Endografts Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Aortic Endografts Market Size and Volume Forecast by Type
13.7.1. Abdominal Aortic Endografts
13.7.2. Thoracic Aortic Endografts
13.7.3. Fenestrated and Branched Aortic Endografts
13.7.4. Flow Diverting Aortic Endografts
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Aortic Endografts Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Aortic Endografts Market: Market Share Analysis
14.2. Aortic Endografts Distributors and Customers
14.3. Aortic Endografts Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bolton Medical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Braile Biomedica
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cardiatis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cook Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cordis (Cardinal Health)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Endologix, Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Endospan
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Jotec
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Lombard Medical Technologies Plc
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Medtronic Plc
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Microport Medical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Nano Endoluminal
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Terumo Medical Corp.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Transcatheter Technologies
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. TriVascular Inc.
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Vascutek
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. W. L. Gore and Associates
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
